ERP29
Basic information
Region (hg38): 12:112013348-112023449
Previous symbols: [ "C12orf8" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ERP29 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 23 | 23 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 23 | 0 | 0 |
Variants in ERP29
This is a list of pathogenic ClinVar variants found in the ERP29 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-112013472-G-A | not specified | Uncertain significance (Jun 10, 2022) | ||
12-112013478-G-A | not specified | Uncertain significance (Oct 26, 2022) | ||
12-112013481-C-A | not specified | Uncertain significance (Dec 20, 2024) | ||
12-112013502-C-T | not specified | Uncertain significance (Jan 31, 2024) | ||
12-112013512-C-G | not specified | Uncertain significance (Dec 14, 2021) | ||
12-112013515-T-C | not specified | Uncertain significance (Apr 14, 2022) | ||
12-112013523-G-A | not specified | Uncertain significance (Dec 08, 2021) | ||
12-112013535-C-T | not specified | Uncertain significance (Aug 30, 2022) | ||
12-112013565-C-T | not specified | Uncertain significance (May 08, 2023) | ||
12-112019778-T-C | not specified | Uncertain significance (Nov 20, 2023) | ||
12-112019792-G-A | not specified | Uncertain significance (Jan 24, 2025) | ||
12-112019850-C-T | not specified | Uncertain significance (Oct 20, 2024) | ||
12-112019858-A-G | not specified | Uncertain significance (Dec 14, 2023) | ||
12-112019861-G-A | not specified | Uncertain significance (Oct 29, 2024) | ||
12-112019874-T-C | not specified | Uncertain significance (Dec 21, 2022) | ||
12-112022176-C-A | not specified | Uncertain significance (Jan 22, 2024) | ||
12-112022224-C-T | not specified | Uncertain significance (Dec 20, 2023) | ||
12-112022267-G-A | not specified | Uncertain significance (Dec 05, 2022) | ||
12-112022312-G-C | not specified | Uncertain significance (May 24, 2024) | ||
12-112022416-G-C | not specified | Uncertain significance (Jan 26, 2025) | ||
12-112022495-T-C | not specified | Uncertain significance (Jun 16, 2024) | ||
12-112022506-G-A | not specified | Uncertain significance (Sep 26, 2022) | ||
12-112022518-G-A | not specified | Uncertain significance (Dec 10, 2024) | ||
12-112022556-G-T | not specified | Uncertain significance (Oct 13, 2023) | ||
12-112022618-T-A | not specified | Uncertain significance (Feb 28, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ERP29 | protein_coding | protein_coding | ENST00000261735 | 3 | 10136 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.751 | 0.247 | 125721 | 0 | 26 | 125747 | 0.000103 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.181 | 144 | 150 | 0.958 | 0.00000825 | 1699 |
Missense in Polyphen | 23 | 39.058 | 0.58887 | 503 | ||
Synonymous | 0.396 | 63 | 67.1 | 0.939 | 0.00000398 | 522 |
Loss of Function | 2.46 | 1 | 8.93 | 0.112 | 3.77e-7 | 118 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000188 | 0.000188 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000167 | 0.000167 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Does not seem to be a disulfide isomerase. Plays an important role in the processing of secretory proteins within the endoplasmic reticulum (ER), possibly by participating in the folding of proteins in the ER.;
- Pathway
- Protein processing in endoplasmic reticulum - Homo sapiens (human);Ibuprofen Action Pathway;Phenytoin (Antiarrhythmic) Action Pathway;Ibuprofen Metabolism Pathway;Morphine Metabolism Pathway;Irinotecan Action Pathway;Morphine Action Pathway;Etoposide Action Pathway;Sorafenib Metabolism Pathway;Acetaminophen Metabolism Pathway;Vitamin A Deficiency;Irinotecan Metabolism Pathway;Etoposide Metabolism Pathway;Retinol Metabolism
(Consensus)
Recessive Scores
- pRec
- 0.199
Intolerance Scores
- loftool
- 0.224
- rvis_EVS
- -0.14
- rvis_percentile_EVS
- 43.57
Haploinsufficiency Scores
- pHI
- 0.0941
- hipred
- N
- hipred_score
- 0.295
- ghis
- 0.604
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.973
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Erp29
- Phenotype
Gene ontology
- Biological process
- activation of MAPK activity;positive regulation of protein phosphorylation;protein folding;intracellular protein transport;protein secretion;positive regulation of gene expression;negative regulation of gene expression;protein unfolding;negative regulation of protein secretion;regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway
- Cellular component
- endoplasmic reticulum;endoplasmic reticulum lumen;smooth endoplasmic reticulum;cell surface;membrane;transport vesicle;melanosome
- Molecular function
- protein disulfide isomerase activity;protein homodimerization activity;chaperone binding